IP Verse

Method Of Treating Cancer Using Selective Estrogen Receptor Modulators

Patent No. EP3122426 (titled "Method Of Treating Cancer Using Selective Estrogen Receptor Modulators") was filed by Duke University on Mar 28, 2015. The application was issued on Jan 18, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZOct 18, 2023ELKINGTON AND FIFE
TEVA PHARMACEUTICALSOct 4, 2023VON KAUFFMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3122426

DUKE UNIVERSITY
Application Number
EP15769394A
Filing Date
Mar 28, 2015
Status
Granted And Under Opposition
Dec 16, 2022
Publication Date
Jan 18, 2023
External Links
Slate, Register , Google Patents